News Summaries

Doctors Perform Groundbreaking Remote Robotic Surgery From China to Tibet and Poland

A team of Chinese surgeons has taken medical care to a new frontier by operating on patients thousands of miles away using cloud‑based robotic technology. On March 20, the International Robotic Remote Surgery Control Center at West China Hospital of Sichuan University completed six fully remote procedures, proving that distance is no longer a barrier to high‑precision surgery. One of the highlights was Vice President Wu Hong, a liver‑transplant specialist, who successfully removed a parasitic cyst (echinoccosis) from a patient in Lhasa, Tibet, while staying in the control room in Chengdu. Earlier this month, the same system was used to assist a surgeon in Poland, marking the first cross‑continental robotic operation of its kind. The technology works by linking a surgeon’s console to a robotic arm at the patient’s bedside via a secure, high‑speed internet connection, allowing real‑time control and feedback. Experts say this approach could bring world‑class expertise to remote or underserved regions, reduce travel costs for patients, and speed up the spread of advanced surgical techniques worldwide. As more hospitals adopt the platform, the vision of a truly global operating room—where the best surgeon can operate from anywhere—appears increasingly within reach.

Navy Teams Up with Gecko Robotics for Record‑Breaking Ship‑Inspection Deal

The U.S. Navy has just signed its biggest robotics contract ever, partnering with Boston‑based Gecko Robotics to overhaul how its fleet gets serviced. Gecko’s small, spider‑like robots will crawl into every nook and cranny of aircraft carriers, destroyers and submarines, gathering high‑resolution data that the company’s software turns into a detailed “digital twin” of each vessel. Those virtual replicas let engineers spot corrosion, cracks or wear long before a problem becomes visible, allowing maintenance crews to fix issues while ships are still at sea instead of waiting for a dry‑dock appointment. CEO Jake Loosararian told TechCrunch the goal is to keep critical assets running as long as possible and eliminate surprise breakdowns. "I want to live in a world where we don’t have ships going through maintenance cycles because we just know what’s broken and what to fix while they’re actually deployed," he said. The system also predicts when parts will need replacement, helping the Navy cut downtime and save millions in repair costs. Beyond the military, Loosararian sees the technology spilling over into power plants, factories and other high‑value infrastructure, promising a future where robots and AI keep the world’s most important machines humming smoothly.

Quantum Computing Funding Booms: Q1 2026 Deals Match Whole‑Year 2025 Levels

Investment in China’s quantum‑computing sector is heating up faster than ever. In the first quarter of 2026, 17 financing rounds poured in about 2.2 billion yuan, almost the total amount raised across the entire year of 2025. The rush reflects growing confidence that quantum technology is moving from laboratory experiments to commercial products. Capital is spreading across three main technology paths. Photonic quantum, which can run at room temperature and plugs into existing fiber networks, attracted the most money (≈2.6 billion yuan). Superconducting quantum, the route pursued by Google and IBM, drew 1.6 billion yuan despite its need for ultra‑cold refrigerators. Quantum precision measurement and emerging neutral‑atom platforms also secured sizable funding. Geographically, the money clusters in three hubs: Hefei, Beijing and Shanghai, together accounting for roughly 73 % of all financing. Hefei’s “Quantum Avenue” hosts a full ecosystem from chips to applications, while Beijing’s university‑linked firms and Shanghai’s state‑backed funds drive rapid growth. Two startups have already hit unicorn status—Guoyi Quantum (8 billion yuan valuation) and Turing Quantum (7 billion yuan). Investors are shifting from team‑centric bets to metrics like qubit count and engineering capability. Analysts advise short‑term focus on supporting hardware and software, medium‑term bets on domain‑specific quantum solutions, and long‑term patience for breakthroughs in error correction and general‑purpose quantum computers.

Breakthrough Portable Terahertz Scanner Could Diagnose Skin Cancer in Real Time

Scientists at the University of Warwick have unveiled a game‑changing terahertz (THz) imaging device that is small enough to fit on a tabletop yet fast enough to capture live, high‑resolution pictures of human tissue. Published in *Nature Communications*, the study shows the new system can scan skin and other soft tissues without any incisions, delivering results in seconds instead of minutes. Traditional THz scanners are bulky, expensive, and require patients to stay still for long periods, limiting their use to research labs. By integrating a high‑speed detector with a compact, low‑power laser source, the Warwick team achieved a dramatic boost in both sensitivity and speed while keeping the whole setup portable. Professor Emma MacPherson, who led the work, explains that the technology “opens the door to real‑time, non‑invasive diagnostics that could be used right in a doctor’s office or even at the bedside.” The most immediate application could be the rapid identification of skin cancers, allowing doctors to spot malignant cells without a biopsy. Beyond dermatology, the device could aid in monitoring burns, wounds, and other conditions where quick, painless imaging is crucial. If adopted widely, this compact THz scanner could transform how clinicians detect and treat disease, moving advanced imaging out of the lab and into everyday medical practice.

AI Boosts Gene‑Editing Accuracy: Safer, Faster DNA Fixes from Singapore Researchers

Scientists at the Yong Loo Lin School of Medicine, National University of Singapore, have teamed up artificial intelligence with gene‑editing to create a far more precise and safer way to repair DNA. Their new approach upgrades tiny “base editors,” which act like molecular scissors that can correct single‑letter mistakes in our genetic code without cutting the whole strand. To measure how well different editors work, the team invented a scoring system called the Base Editor Performance Index (BEPI). Using AI‑driven protein modeling and a novel screening platform, they refined a compact enzyme named SsdAtox. The AI‑guided tweaks boosted the enzyme’s editing efficiency by up to 11.8 times while dramatically cutting DNA damage and cellular toxicity. In plain terms, the upgraded tool can fix genetic errors more reliably and with fewer side effects, a crucial step toward safer gene‑therapy treatments for diseases such as sickle‑cell anemia and certain cancers. The breakthrough shows how machine learning can accelerate biomedical innovation, turning complex lab work into faster, more trustworthy therapies for patients worldwide.

Exosome ‘Miracle’ Treatments: Why the New Anti‑Aging Injections May Be Dangerous

Exosomes are microscopic “information parcels” that cells use to exchange proteins and genetic material. Scientists have been studying them for years and even won a Nobel Prize for uncovering how cells package and deliver these parcels. The excitement has turned into a booming market: clinics advertise exosome‑filled injections as a fountain of youth or a cure for brain disorders. However, no exosome‑based drug has been approved anywhere in the world. CCTV’s recent 3·15 report revealed that many providers bypass regulations by using unrelated medical‑device certificates, injecting products whose ingredients are unclear. Patients have suffered infections, severe acne and, in some cases, organ damage – essentially becoming unpaid test subjects. The root problem is a gap between early‑stage research and commercial hype. China’s drug regulator is drafting rules that would classify therapeutic exosome products as drugs, requiring clinical trials before they can be sold. Until those standards are in place and enforced, consumers should treat any exosome injection or supplement that lacks official approval with extreme caution.

China’s Tianjin Institute Pioneers AI‑Powered Biomanufacturing for a Self‑Sufficient Future

The Tianjin Institute of Industrial Biotechnology is stepping into the spotlight as China’s new champion of biomanufacturing. Rather than relying on imported technology, the institute is building its own cutting‑edge capabilities, using artificial intelligence to design proteins and cells that can produce medicines, bio‑fuels, and other high‑value products. Imagine a digital lab where computers predict the best molecular structures, then scientists bring those designs to life in large‑scale bioreactors. The institute’s roadmap includes three bold moves: first, AI‑driven protein and cell engineering that speeds up discovery and cuts costs; second, turning renewable energy sources into useful chemicals through advanced bioconversion processes; and third, scaling up engineering biology with massive, state‑of‑the‑art facilities that can produce everything from biodegradable plastics to vaccine components. By tackling these challenges head‑on, Tianjin aims to place China at the forefront of the global biotech race, reducing dependence on foreign tech and creating home‑grown solutions for health, energy, and the environment. The initiative reflects a broader national push for technological self‑reliance, promising new jobs, greener production methods, and a stronger, more independent scientific ecosystem.